Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects | Zendy

Robert R. Henry | Zendy; Sunder Mudaliar | Zendy; Theodore P. Ciaraldi | Zendy; Debra Armstrong | Zendy; P. Burke | Zendy; Jeremy Pettus | Zendy; Parag Garhyan | Zendy; Siak Leng Choi | Zendy; Scott J. Jacober | Zendy; Mary Pat Knadler | Zendy; Eric Chen Quin Lam | Zendy; Melvin Prince | Zendy; Namrata Bose | Zendy; Niels Pörksen | Zendy; Vikram Sinha | Zendy; Helle Linnebjerg | Zendy

Open Access

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

Author(s) -

Robert R. Henry,

Sunder Mudaliar,

Theodore P. Ciaraldi,

Debra Armstrong,

P. Burke,

Jeremy Pettus,

Parag Garhyan,

Siak Leng Choi,

Scott J. Jacober,

Mary Pat Knadler,

Eric Chen Quin Lam,

Melvin Prince,

Namrata Bose,

Niels Pörksen,

Vikram Sinha,

Helle Linnebjerg

Publication year - 2014

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc14-0210

Subject(s) - insulin glargine , medicine , endocrinology , insulin , basal (medicine) , basal insulin , insulin analog , crossover study , diabetes mellitus , stimulation , type 2 diabetes , human insulin , hypoglycemia , placebo , alternative medicine , pathology

We evaluated the endogenous glucose production (EGP) and glucose disposal rate (GDR) over a range of doses of basal insulin peglispro (BIL) and insulin glargine in healthy subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research